[ASAP] Bifunctionality and Antitumor Efficacy of ZG-126, a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule

AI Summary

This article discusses the development of a hybrid molecule called ZG-126, which serves as both a vitamin D receptor agonist and a histone deacetylase inhibitor. The study explores the bifunctionality of ZG-126 and its potential antitumor efficacy. This research is significant as it highlights the potential of hybrid molecules in targeting cancer cells through multiple pathways, offering new possibilities for cancer treatment.

Leave a Reply